Humanigen
Patents, Design & Utilities

Last updated:

List of all Humanigen patents 19 in total

Status Patent
Application
Utility: MATERIALS AND METHODS FOR TREATING CANCER External link
Filling date: 6 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 27 Jan 2022
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY External link
Filling date: 6 Sep 2025 Issue date: 7 Oct 2021
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: MATERIALS AND METHODS FOR TREATING CANCER External link
Filling date: 6 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS External link
Filling date: 6 Sep 2025 Issue date: 12 Aug 2021
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 6 May 2021
Grant
Utility: Method of reducing tumor relapse rate in immunotherapy by administration of lenzilumab External link
Filling date: 6 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Immunoglobulin variable region cassette exchange External link
Filling date: 6 Sep 2025 Issue date: 16 Feb 2021
Grant
Utility: Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy-related toxicity External link
Filling date: 6 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist External link
Filling date: 6 Sep 2025 Issue date: 22 Dec 2020
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 12 Nov 2020
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST External link
Filling date: 6 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: EPHA3 ANTIBODIES FOR THE TREATMENT OF PULMONARY FIBROSIS External link
Filling date: 6 Sep 2025 Issue date: 5 Sep 2019

Showing 1 to 19 of 19 patents.